MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinson’s"

  • MDS Virtual Congress 2021

    Clinical and Economic Outcomes Associated with Dysphagia in Hospitalized Patients with Parkinson’s Disease

    D. Di Luca, E. Mcarthur, A. Willis, R. Martino, C. Marras (Toronto, Canada)

    Objective: To evaluate the outcomes associated with dysphagia in hospitalized patients with Parkinson's Disease and associated healthcare costs and utilization. Background: Dysphagia in Parkinson's Disease…
  • MDS Virtual Congress 2021

    Methods for addressing missing covariate data in left truncated samples with application to Parkinson’s disease research

    H. Richardson, S. Xie (Philadelphia, USA)

    Objective: To investigate the impact of left truncation on commonly used missing data approaches and explore this impact in a Parkinson’s disease dementia study. Background:…
  • MDS Virtual Congress 2021

    Risk of cancer in Parkinsons’s disease: a systematic review of diagnostic validity

    A. Mehdiyeva, V. Kaasinen, J. Mauri, J. Sipilä (Joensuu, Finland)

    Objective: We systematically reviewed studies to investigate a possible association between validated PD diagnoses and cancer risk. Background: An inverse association between Parkinson’s disease (PD)…
  • MDS Virtual Congress 2021

    Telephone Visit Efficacy for Parkinson’s Disease During the COVID-19 Pandemic

    F. Abu Ahmad, R. Postuma (Montreal, Canada)

    Objective: To compare telephone and in-person visits in the clinical care of Parkinson’s disease (PD) patients. Background: There has been growing interest in using telemedicine…
  • MDS Virtual Congress 2021

    Central pain in Parkinson’s disease

    M. Elfekih, I. Bedoui, B. Douma, M. Mansour, H. Derbali, A. Riahi, M. Messelmani, J. Zaouali, R. Mrissa (Nabeul, Tunisia)

    Objective: The objective of our study is to assess the prevalence of central pain in patients with parkinson’s diseaseThe objective of our study is to…
  • MDS Virtual Congress 2021

    Measuring progression of Parkinson’s disease cardinal signs in the Phase 2 SPARK study

    KP. Kilambi, T. Dam, J. Edgerton, T. Fox, S. Khan, J. Xiao, M. Yang, P. Bergethon (Cambridge, USA)

    Objective: To evaluate a novel quantitative measure of Parkinson’s disease (PD) severity and progression in a Phase II clinical trial. Background: Cinpanemab, a monoclonal antibody,…
  • MDS Virtual Congress 2021

    Randomised Controlled Trial Comparing Efficacy of Zonisamide 25 mg given in addition to standard treatment with standard treatment alone in Tremor dominant Parkinson’s Disease- A Pilot study.

    K. Pillai, V. Goyal, A. Srivastava, R. Rajan, P. Srivastava, M. Singh, V. V.Y, D. Radhakrishnan, A. Elavarasi, P. Bhat (New Delhi, India)

    Objective: To compare improvement in  tremor at 12 weeks with Zonisamide  given in  a dose of  25 mg  along with other ant- parkinsonian drugs as…
  • MDS Virtual Congress 2021

    Effect of Ketone Ester Supplementation on Motor and Non-Motor symptoms in Parkinson’s Disease

    M. Beke, P. Mackie, C. Rusch, E. Klann, A. Gurrala, S. Chua, E. Ince, L. Almeida, A. Ramirez-Zamora (Gainesville, USA)

    Objective: To investigate the effect of exogenous ketone ester supplementation on motor and non-motor symptoms in Parkinson’s Disease (PD). Background: Animal research and human pilot…
  • MDS Virtual Congress 2021

    THE EFFECT OF VITAMIN D IN PARKINSON’S DISEASE

    E. Göger, G. Yüksel, G. Gürsoy (İstanbul, Turkey)

    Objective: The objective of this study is to investigate the role of vitamin D deficiency (VDD) as an etiopathological factor in Parkinson's disease (PD). Background:…
  • MDS Virtual Congress 2021

    Influence of Dopamine Transporter Gene Polymorphism on Wearing Off

    CE. Mantese, V. Altmann, A. Schumacher-Schuh, M. Hutz, CRM. Rieder (Porto Alegre, Brazil)

    Objective: To study the influence of Dopamine transporter gene polymorphism on Wearing off (WO) through 19 items wearing off questionnaire (WOQ-19) Background: The dopamine transporter…
  • « Previous Page
  • 1
  • …
  • 422
  • 423
  • 424
  • 425
  • 426
  • …
  • 436
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley